44 results about "Ophthalmia" patented technology

The invention relates to the novel use of human lysozyme, in particular the use of human lysozyme in pharmaceutical industry, specifically the use of human lisozima in preparing ophthalmocace treating medicine, such as epidemic conjunctivitis, opthalmitis, ceratitis, corneal ulcer diseases caused by bacterium, Chlamydia, viruses and drug resistant medicines. The gene recombination lysozyme has rich source, the eye drops prepared thereby are easy to use.

On the research basis that microbes of specific species are present in eyes of patients with different eye diseases, the invention discloses a method for establishing a model, and the method comprisesthe step of infecting a model carrier with the microbes. The model prepared by the method can be used for screening drugs for the eye diseases, and the eye diseases include senile macular degeneration, the behcet disease, the Vogt-Koyanagi-Harada syndrome, uveitis, retinopathy, xerophthalmia, sympathetic ophthalmia, trachoma, cataract, conjunctivitis, chalazion, glaucoma, muscae volitantes and the like.

The invention discloses new application for pien tze huang in the aspect of protecting a memory function and resisting cerebral ischemia. The pien tze huang belongs to a traditional first-grade state-protection traditional Chinese medicine, is processed and prepared into various types of conventional formulations applied clinically, has effects of inflammation diminishing, cooling, detoxication, detumescence, pain relieving and the like, has good curative effects for diseases of pain, fever and the like caused by oxyhepatitis, ophthalmia, otitis and all inflammations, and further has an obvious inhibiting effect for cancer cells of the digestive system of a patient. The pien tze huang in the invention has a remarkable effect in the aspect of protecting the memory function and resisting cerebral ischemia. In addition, preventive therapy by the aid of the pien tze huang can relieve apoplexy severity and prolong survival life of patients with apoplexy, and simultaneously, the effect of the pien tze huang is confirmed. Mechanism research of the new application for the pien tze huang is realized, and accordingly, the new application for the pien tze huang has a more scientific basis.

The present invention is one kind of Chinese medicine composition for treating electric ophthalmia and belongs to the field of Chinese medicine technology. The Chinese medicine is prepared with prepared rhizome of rehmannia, Chinese fevervine and borneol as main material, and the preferred composition is prepared rhizome of rehmannia 45-55 weight portions, Chinese fevervine 35-45 weight portions and borneol 5-15 weight portions. The Chinese medicine composition can reduce eye's pain fast and conjunctiva hyperemia fast, nourish and repair damaged eye tissue and restore eyesight.

A method of treating blepharitis includes administering to the affected eye of a subject an effective amount of an active ingredient in an ophthalmically acceptable vehicle for a sufficient period of time to treat blepharitis. The active ingredient consists essentially of a glucocorticoid in an ophthalmically acceptable vehicle that includes an aqueous polymer suspension that when mixed with tear fluid provides a sustained release of said active ingredient. The aqueous polymer suspension includes a carboxyl-containing polymer having less than about 5% by weight cross-linking agent and has a viscosity in a range from about 1,000 to about 30,000 centipoises. A kit includes: (a) a composition comprising about 0.1% by weight dexamethasone in this ophthalmically acceptable vehicle and (b) instructions for using the composition of (a) for the treatment of blepharitis.

The invention belongs to the technical field of medicines and discloses a pharmaceutical preparation for treating electric ophthalmia. The pharmaceutical preparation for treating electric ophthalmia is prepared from the following raw materials: coptis chinensis, concha haliotidis, rhizoma alismatis, fructus cnidii, medicinal cyathula roots, radix paeoniae alba, roots of kudzu vines, pipewort, seeds of feather cockscomb, mother chrysanthemum, curcuma zedoary, fructus forsythia, wolfberries, amomun kravanh, selfheal, pericarpium citri reticulatae, liquorice, radix ophiopogonis, fructus kochiae and angelica sinensis. The pharmaceutical preparation provided by the invention is short in treatment cycle, quick to take effect and simple in preparation process.

The invention relates to a Chinese medicinal composition for treatment of edema and ophthalmia and a preparation method thereof. The Chinese medicinal composition is characterized by having the efficacy of clearing away heat and toxic materials, resisting inflammation, inducing diuresis and reducing edema, dispelling wind and removing obstruction in meridians, stopping bleeding, invigorating blood circulation and alleviating pain, etc., and can eliminate edema symptom proteinuria, hematuria, erythrocyte cylindruria, dropsy, high blood pressure, inflammation and the like. The matrix is prepared from the following Chinese medicinal composition and pharmaceutical excipients by weight: 1-50 parts of Scutellaria baicalensis, 1-100 parts of Stephania longa, 1-50 parts of acorus gramineus, and 1-50 parts of Pseudo-ginseng. The composition of the invention cares the whole of human body, prevents complications, treats both symptoms and root causes, has no toxic or side effect, and also has significant curative effect on some symptoms on which western medicines are non-effective. The composition provided by the invention is applied to clinical treatment of 12 edema cases, wherein the minimum age is 6 years old, the maximum age is 48 years old, the shortest disease course is 5 days, the longest disease course is 3 months, and all the cases are cured. The composition is applied to treatment of 26 ophthalmia cases, wherein the minimum age is 4 years old, the maximum age is 56 years old, the shortest disease course is 1 day, the longest disease course is 15 days, and all the cases are cured.

The invention discloses novel application of Pien Tze Huang and a preparation of Pien Tze Huang to the protection of a memory function and the resistance of cerebral ischemia. Pien Tze Huang, which is taken as the traditional national first-class Chinese medicine protection variety, is prepared into multiple kinds of conventional formulations which are clinically applied at present; Pien Tze Huang has the effects of reducing inflammation, cooling, releasing toxin, relieving swelling and pain and the like, and has a good effect of treating diseases such as pain and fever which are caused by acute hepatitis, ophthalmia and otitis as well as all inflammations; and in addition, Pien Tze Huang has a remarkable effect of inhibiting cancer cells of digestive systems. Pien Tze Huang has remarkable effects of protecting the memory function and resisting cerebral ischemia. The novel application of Pien Tze Huang is subjected to mechanism research, so that the novel application of Pien Tze Huang has a relatively scientific basis.

The invention belongs to the technical field of medicines and discloses a preparation process of a protection product used for treating electric ophthalmia of electric power staff. The protection product is prepared from the following raw materials: divaricate saposhnikovia root, peppermint, coptis root, Mongolian dandelion herb, sappan wood, dahurian patrinia herb, chrysanthemum, barbary wolfberry fruit, cicada slough, Chinese date, mulberry fruit, buerger pipewort flower, cape jasmine fruit, feather cockscomb seed, myrrh, glossy privet fruit, Indian buead, honeysuckle flower, mulberry leaf, Chinese dodder seed, Danshen root and liquorice root. The medicine preparation has short treatment cycle and takes effect quickly. The preparation process is simple.

The invention discloses a Chinese medicament for local use on ophthalmology prepared by using Huangtengsu as the main component, wherein the dosages types include eye ointment, eye gel and eye drop. The ophthalmology preparation not only has good effect in treating opthalmitis caused by bacteria and fungus, but also has appreciable protection action to chemical opthalmitis.

A method of treating non-infectious, inflammatory blepharitis includes administering to the affected eye of a subject an effective amount of an active ingredient in an ophthalmically acceptable vehicle for a sufficient period of time to treat the non-infectious, inflammatory blepharitis. The active ingredient consists essentially of a glucocorticoid in an ophthalmically acceptable vehicle that includes an aqueous polymer suspension that when mixed with tear fluid provides a sustained release of said active ingredient. The aqueous polymer suspension includes a carboxyl-containing polymer having less than about 5% by weight cross-linking agent and has a viscosity in a range from about 1,000 to about 30,000 centipoises. A kit includes: (a) a composition comprising about 0.1% by weight dexamethasone in this ophthalmically acceptable vehicle and (b) instructions for using the composition of (a) for the treatment of blepharitis.

The invention discloses new application for pien tze huang in the aspect of protecting a memory function and resisting cerebral ischemia. The pien tze huang belongs to a traditional first-grade state-protection traditional Chinese medicine, is processed and prepared into various types of conventional formulations applied clinically, has effects of inflammation diminishing, cooling, detoxication, detumescence, pain relieving and the like, has good curative effects for diseases of pain, fever and the like caused by oxyhepatitis, ophthalmia, otitis and all inflammations, and further has an obvious inhibiting effect for cancer cells of the digestive system of a patient. The pien tze huang in the invention has a remarkable effect in the aspect of protecting the memory function and resisting cerebral ischemia. In addition, preventive therapy by the aid of the pien tze huang can relieve apoplexy severity and prolong survival life of patients with apoplexy, and simultaneously, the effect of the pien tze huang is confirmed. Mechanism research of the new application for the pien tze huang is realized, and accordingly, the new application for the pien tze huang has a more scientific basis.

The present invention discloses eye medicine preparation with effective component extracted from shellfish meat and its use. There is high content of taurine in retina as the important factor of photoreceptor, and lack of taurine will result in the degradation and the optical conductance suppression of the photoreceptor. Shellfish meat contains rich amino acid, especially taurine, and trace elements and zinc, so that effective component is extracted from shellfish meat and prepared into eye medicine preparation. The pharmacological experiments show that the medicine of the present invention can treat cataract, eliminating eye fatigue, correct eyesight, resist inflammation, and treat acute and chronic conjunctivitis, ceratitis and other eye diseases.